Search Results

Filter
  • 1-10 of  26,145 results for ""Insulin Aspart""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A comparison of the safety and effectiveness of insulin aspart with other bolus insulins in women with pre-existing Type 1 diabetes during pregnancy: A post hoc analysis of a prospective cohort study.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood ; Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/administration & dosage

  • Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2024 Oct; Vol. 41 (10), pp. e15411. Date of Electronic Publication: 2024 Aug 08.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of multi-disulfide bridges for insulin aspart by stepwise reduction and differentiated alkylation.

  • Authors : Cui X; Department of Bioengineering, Beijing Technology and Business University, Beijing, 100048, PR China.; Meng X

Subjects: Disulfides*/Disulfides*/Disulfides*/chemistry ; Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/chemistry; Alkylation

  • Source: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2024 Dec; Vol. 416 (29), pp. 6725-6733. Date of Electronic Publication: 2024 Oct 30.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial.

  • Authors : Søholm JC; Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark.; Department of Nephrology and Endocrinology, Rigshospitalet, Copenhagen, Denmark.

Subjects: Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/therapeutic use ; Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/administration & dosage ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy

  • Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2025 Jan; Vol. 42 (1), pp. e15467. Date of Electronic Publication: 2024 Nov 04.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.

  • Authors : Cohen E; Department of Biomedical Engineering, McGill University, Montreal, QC, Canada.; Tsoukas MA

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Cross-Over Studies* ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: The Lancet. Digital health [Lancet Digit Health] 2024 Jul; Vol. 6 (7), pp. e489-e499.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print Cited Medium: Internet ISSN: 2589-7500

Record details

×
Academic Journal

Comparative assessment of immunogenicity of recombinant insulin Aspart from BioGenomics and its originator NovoRapid® in adult patients with type 2 diabetes mellitus.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/immunology ; Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/immunology

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2024 Jun; Vol. 47 (6), pp. 1435-1446. Date of Electronic Publication: 2023 Dec 26.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1720-8386

Record details

×
Academic Journal

Glycaemic outcomes in hospital with IDegAsp versus BIAsp30 premixed insulins.

  • Authors : Walt JR; Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Royal Melbourne Clinical School, The University of Melbourne, Melbourne, Victoria, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Blood Glucose*/Blood Glucose*/Blood Glucose*/drug effects

  • Source: Internal medicine journal [Intern Med J] 2024 Aug; Vol. 54 (8), pp. 1329-1336. Date of Electronic Publication: 2024 Apr 05.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Functional insulin aspart/insulin degludec-based microneedles for promoting postprandial glycemic control.

  • Authors : Chen BZ; State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, China; Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.

Subjects: Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/therapeutic use ; Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/drug therapy; Humans

  • Source: Acta biomaterialia [Acta Biomater] 2023 Nov; Vol. 171, pp. 350-362. Date of Electronic Publication: 2023 Sep 13.Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568

Record details

×
Academic Journal

Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes.

  • Authors : Haliloglu B; Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom.; Division of Paediatric Endocrinology and Diabetes, Marmara University School of Medicine, Istanbul, Turkiye.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood ; Postprandial Period*

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Jul; Vol. 26 (7), pp. 449-456. Date of Electronic Publication: 2024 Feb 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart.

Subjects: Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/pharmacology ; Receptor, Insulin*; Animals

  • Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2023 Sep; Vol. 37 (5), pp. 709-719. Date of Electronic Publication: 2023 Jun 07.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial.

  • Authors : Dovc K; Department of Endocrinology, Diabetes and Metabolism, University Children's Hospital, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Subjects: Insulin Aspart*/Insulin Aspart*/Insulin Aspart*/therapeutic use ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Female

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Sep; Vol. 25 (9), pp. 612-621.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  26,145 results for ""Insulin Aspart""